Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00058448 · ClinicalTrials.gov registry record · Phase 2

S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)

A Phase 2 study, sponsored by SWOG Cancer Research Network.

Terminated
Registry status
Phase 2
Development phase
1
Enrollment target

NCT00058448: Clinical Trial Phase 2 study, sponsored by SWOG Cancer Research Network.

NCT00058448 is a Phase 2 study that was terminated before completion, run by SWOG Cancer Research Network. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00058448, a Phase 2 study, was terminated before completion, sponsored by SWOG Cancer Research Network.

TERMINATED
Registry status
Phase 2
Development phase
1 participants
Enrollment target

Study Summary

RATIONALE: Drugs used in chemotherapy such as docetaxel use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients who have locally advanced or metastatic penile cancer.

Interventions

  • DRUG docetaxel

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2004-10
Est. Completion 2005-11
Phase Phase 2
SWOG Cancer Research Network

270 total trials

Why NCT00058448 stopped before completion

NCT00058448 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which docetaxel is the first listed.

NCT00058448 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00058448 about?

NCT00058448 is a clinical study titled "S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)". RATIONALE: Drugs used in chemotherapy such as docetaxel use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients who have locally advanced or metastatic penile cancer.

What is the current status of trial NCT00058448?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2004-10. Estimated completion is 2005-11.

What interventions are being tested in trial NCT00058448?

The interventions under investigation include: docetaxel (DRUG).

Who is sponsoring clinical trial NCT00058448?

This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00058448's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00058448, the US trial registry maintained by the National Library of Medicine. NCT00058448 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.